Live Chat

What Can We Do About Risperdal’s Side Effects?

Last month, Huffington Post published a 58,000 word series on Johnson & Johnson’s illegal marketing of the dangerous drug Risperdal. Risperdal is proven to cause young boys to grow large breasts. The series exposes unethical and illegal behavior from Johnson and Johnson since Risperdal’s release in 1994. We can all take steps to ensure that Johnson & Johnson is accountable for manufacturing and selling dangerous drugs. As an informed consumer, each one of us can avoid drugs produced by such companies, who have long histories of questionable methods. Read the labels of all drugs, both prescription drugs and over-the-counter drugs. Ask your doctor about other options for drugs that are not promoted or sold by companies that have outstanding litigation. Most importantly, you can bring these issues to light in litigation by filing a lawsuit when you or one of your loved ones is harmed by a dangerous drug.
Legal Commentary
The antipsychotic drug Risperdal has been linked to breast development in young boys. Psychopharmacology published first study results in January 1999, associating Risperdal with gynecomastia. The study reported Risperdal caused gynecomastia when used in conjunction with the antidepressant Prozac, which contains fluoxetine. Patients who have developed Risperdal gynecomastia are encouraged to speak with an experienced pharmaceutical injury attorney immediately. Risperdal has been proven to cause breast development in young boys, or pituitary cancer and tumors. Other symptoms of Risperdal caused gynecomastia include pain, tenderness, or swelling of the breasts, and/or nipple discharge. Gynecomastia can be emotionally and psychologically damaging, and may require surgical correction. If you or a loved one took Risperdal to treat bipolar disorder, schizophrenia, or behavioral issues associated with autism, you may be entitled to cash compensation. Contact our team of attorneys today by email or phone at +1.888.545.7402 for a free evaluation of your case today.
Drug Litigation